Product development & scale-up
Designing a credible path from prototype to repeatable production.
Our team brings product-development, engineering, design-transfer, manufacturing and supplier experience across regulated medical technologies. Product requirements, process capability, quality, usability and cost are treated as connected decisions.
This practical focus helps teams build manufacturability and scale into the programme early, before a promising prototype defines an expensive or fragile path.
Product, engineering and manufacturing expertise
Venture & company building
Turning medical technology into an investable, executable venture.
We support companies from early proposition and spinout through feasibility, intellectual property, outsourced development, quality and regulatory planning, evidence strategy, partnerships and investment readiness.
The work keeps technology, intended use, clinical value, health economics, governance, adoption and funding aligned as the business moves from ambition into controlled execution.
Venture, investment and company-building expertise
Medtech leadership
Connecting technical, operational and commercial reality.
Senior executive and functional leadership experience spans product and evidence priorities, quality and regulatory needs, cross-functional delivery, organisational design and commercial decision support.
That breadth sharpens our view of where apparently sound strategies fail: unclear ownership, claims that outrun evidence, fragmented priorities and investment cases that do not connect spend to value.
Executive, operational and functional leadership expertise
Evidence and adoption
Designing evidence around the pathway, not only the product.
Our team has shaped evidence and adoption programmes with clinical, academic, health-economic, patient and healthcare-system stakeholders across acute, community and other care settings.
The result is a disciplined approach to market access: define the decision, understand who pays and benefits, identify what could block adoption, then generate the evidence that matters to those stakeholders.
Clinical-development and NHS adoption experience